A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Clinical trial NCT01071252 · COMPLETED

Trial details

NCT number: NCT01071252
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Plaque-type Psoriasis

Start date: 2010-03-01
Primary completion: 2011-02-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.